Human CD8+ T-cell differentiation in response to viruses

Nature Reviews Immunology

Volumn 3, Issue 12, 2003, Pages 931-938

  Van Lier, René A W ^a   Ten Berge, Ineke J M ^a   Gamadia, Laila E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD27 ANTIGEN; CD28 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD70 ANTIGEN; CHEMOKINE RECEPTOR CCR7; EPITOPE; GAMMA INTERFERON; GRANZYME B; HLA ANTIGEN CLASS 1; HLA DR ANTIGEN; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PADGEM PROTEIN; PEPTIDE; PERFORIN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN;

CELL CLONE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL MATURATION; CELL SPECIFICITY; CYTOKINE PRODUCTION; EFFECTOR CELL; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; LATENT VIRUS INFECTION; MEMORY CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SERODIAGNOSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TELOMERE; TH1 CELL; TH2 CELL; VIRUS INFECTION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0346874501     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1254     Document Type: Review

References (104)

1. Kaech, S. M., Wherry, E. J. & Ahmed, R. Effector and memory T-cell differentiation: implications for vaccine development. Nature Rev. Immunol. 2, 251-262 (2002).
2. + T cell responses to infectious pathogens. Annu. Rev. Immunol. 21, 29-70 (2003).
3. + T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177-187 (1998).
4. Berke, G. The CTL's kiss of death. Cell 81, 9-12 (1995).
5. + T cells after infection. Nature Immunol. 3, 619-626 (2002). This paper shows that not only clonal expansion but also clonal contraction might be determined in the initial contact between a T cell and an antigen-presenting cell (APC).
6. + T cell differentiation. Cell 111, 837-851 (2002).
7. Schluns, K. S. & Lefrancois, L. Cytokine control of memory T-cell development and survival. Nature Rev. Immunol. 3, 269-279 (2003).
8. Jordan, M. C., Jordan, G. W., Stevens, J. G. & Miller, G. Latent herpesviruses of humans. Ann Intern. Med. 100, 866-880 (1984).
9. + T lymphocyte response to viral infection during fetal life. J. Clin. Invest. 111, 1747-1755 (2003).
10. Gray, D. A role for antigen in the maintenance of immunological memory Nature Rev. Immunol. 2, 60-65 (2002).
11. Selin, L. K. et al. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 11, 733-742 (1999).
12. Rabin, R. L. et al. Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. J. Clin. Invest. 95, 2054-2060 (1995).
13. + T cells. J. Fxp. Med. 186, 1407-1418 (1997).
14. Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712 (1999).
15. Campbell, J. J. et al. CCR7 expression and memory T cell diversity in humans. J. Immunol. 168, 877-884 (2001).
16. Merkenschlager, M. & Beverley, P. C. Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: human CD8 memory CTLp selectively express CD45RO (UCHL1). Int. Immunol. 1, 450-459 (1989).
17. Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400 (1995).
18. + cells with different requirements for activation and differentiation. J. Immunol. 146, 2088-2094 (1991).
19. + T cells from a memory to memory/effector phenotype. J. Immunol. 168, 5538-5550 (2002).
20. + T cells in the whole body. Nature 410, 101-105 (2001).
21. Masopust, D., Vezys, V., Marzo, A. L. & Lefrancois, L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291, 2413-2417 (2001).
22. + memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers. J. Immunol. 170, 2461-2468 (2003).
23. + T cell subsets. Nature Immunol. 4, 225-234 (2003). This paper addresses the lineage relationship between memory T-cell subsets in vivo, providing evidence that central memory cells might develop from effector-memory cells relatively late after clearance of pathogen.
24. - memory T cells do not differ in immediate effector cell function. J. Immunol. 169, 638-641 (2002).
25. Ellefsen, K. et al. Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections. Eur. J. Immunol. 32, 3756-3764 (2002).
26. - T lymphocytes. J. Immunol. 150, 1147-1159 (1993).
27. + T cells contain cells with high levels of LFA-1 expression, a phenotype of primed T cells. J. Immunol. 150, 429-437 (1993).
28. + T cells closely correlates with CD56 surface expression. J. Immunol. 164, 1148-1152 (2000).
29. + T cells. Blood 101, 2711-2720 (2003).
30. + effector αβ T ceIIs. J. Immunol. 167, 6165-6170 (2001).
31. Bell, E. B. & Sparshott, S. M. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 348, 163-166 (1990).
32. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligodonally or monodonally expanded cell populations. Proc. Natl Acad. Sci. USA 93, 12433-12438 (1996).
33. +. J. Immunol. 165, 1910-1917 (2000).
34. Murphy, K. M. & Reiner, S. L. The lineage decisions of helper T cells. Nature Rev. Immunol. 2, 933-944 (2002).
35. + T cells, J. Immunol. 169, 5838-5843 (2002).
36. Wieranga, E. A. et al. Human atopen-specific types 1 and 2 T helper cell clones. J. Immunol. 147, 2942-2949 (1991).
37. + T subsets with distinct replicative history and partial effector functions. Blood 105, 1779-1787 (2003).
38. Altman, J. D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96 (1996).
39. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 167, 1395-1402 (1998).
40. + T cell memory in vivo. Eur. J. Immunol. 28, 4382-4390 (1998).
41. + T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 195, 893-905 (2002).
42. + T cells. J. Immunol. 168, 4184-4191 (2002).
43. + T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans. J. Infect. Dis. 182,451-458 (2000) This reference, together with references 44 and 46, describe longitudinal studies on primary responses to virus in humans.
44. Appay, V. et al. Dynamics of T cell responses in HIV infection. J. Immunol. 168, 3660-3666 (2002).
45. + T cell response. J. Immunol. 168, 5455-5464 (2002).
46. + T cells in protection against CMV disease. Blood 101, 2686-2692 (2003).
47. Thimme, R. et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194, 1395-1406 (2001).
48. Lechner, F. et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191, 1499-1512 (2000).
49. + lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J. Virol. 76, 12423-12434 (2002).
50. + T cells in large cohorts.
51. + T cell maturation state: potential implications for therapeutic immunization. J. Infect. Dis. 187, 364-374 (2003).
52. + central and effector memory T cell subsets are largely distinct. Immunity 18, 193-204 (2003).
53. + T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J. Immunol. 167, 2019-2029 (2001).
54. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 101, 4260-4266 (2003).
55. + T cells in vitro. Blood 102, 2541-2546 (2003).
56. + T lymphocytes depend on infection with CMV. J. Immunol. 170, 4342-4348 (2003).
57. Khan, N. et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 169, 1984-1992 (2002).
58. + T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J. Immunol. 155, 5046-5056 (1995).
59. Kern, F. et al. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J. Infect. Dis. 185, 1709-1716 (2002).
60. Champagne, P. et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410, 106-111 (2001).
61. + counterparts. J. Immunol. 156, 3587-3590 (1996).
62. + Int. Immunol. 11, 1027-1033 (1999).
63. Posnett, D. N., Sinha, R., Kabak, S. & Russo, C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to 'benign monoclonal gammapathy. J. Exp. Med. 179, 609-618 (1994).
64. Hendriks, J. et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nature Immunol. 1, 433-440 (2000).
65. Arens, R. et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFN-γ-mediated B cell depletion. Immunity 15, 801-812 (2001).
66. Hintzen, R. Q. et al. Regulation of CD27 expression on subsets of mature T-lymphocytes. J. Immunol. 151, 2426-2435 (1993).
67. McMichael, A. J. & Rowland-Jones, S. L. Cellular immune responses to HIV. Nature 410, 980-987 (2001).
68. + T cells is associated with progression to viral disease in HIV-infection. AIDS 16, 2001-2011 (2002).
69. Appay, V. & Rowland-Jones, S. L. Premature ageing of the immune system: the cause of AIDS? Trends Immunol. 23, 580-585 (2002).
70. + T-cell maturation: CD27 might provide a clue. Trends Immunol. 23, 586-591 (2002).
71. + T lymphocytes. Nature 421, 852-856 (2003).
72. + T cell help. Science 300, 339-342 (2003).
73. Shedlock, D. J. & Shen, H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300, 337-339 (2003).
74. Riddell, S. R., Reusser, P. & Greenberg, P. D. Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patients. Rev. Infect. Dis. 13 Suppl. 11, S966-S973 (1991).
75. Lee, P. P. et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nature Med. 5, 677-685 (1999).
76. Dunbar, P. R. et al. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J. Immunol. 165, 6644-6652 (2000).
77. Fong, L. et al. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl Acad. Sci. USA 98, 8809-8814 (2001).
78. Trowbridge, I. S. & Thomas, M. L. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12, 85-116 (1994).
79. Streuli, M., Hall, L. R., Saga, Y., Schlossman, S. F. & Saito, H. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J. Exp. Med. 166, 1548-1566 (1987).
80. Smith, S. H., Brown, M. H., Rowe, D., Callard, R. E. & Beverley, P. C. Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL-1. Immunology 58, 63-70 (1986).
81. Sanders, M. E. et al. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-γ production. J. Immunol. 140, 1401-1407 (1988).
82. Novak, T. J. et al. Isoforms of the transmembrane tyrosine phosphatase CD45 differentially affect T cell recognition. Immunity 1, 109-119 (1994).
83. Springer, T. A. & Lasky, L. A. Cell adhesion. Sticky sugars for selectins. Nature 349, 196-197 (1991).
84. Kannagi, R. Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes. Curr. Opin. Struct. Biol. 12, 599-608 (2002).
85. Janeway, C. A., Jr & Bottomly, K. Signals and signs for lymphocyte responses. Cell 76, 275-285 (1994).
86. June, C. H., Bluestone, J. A., Nadler, L. M. & Thompson, C. B. The B7 and CD28 receptor families. Immunol. Today 15, 321-331 (1994).
87. Linsley, P. S., Bradshaw, J., Urnes, M., Grosmaire, L. & Ledbetter, J. A CD28 engagement by B7/BB-1 induces transient downregulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. J. Immunol. 150, 3161-3169 (1993).
88. Goodwin, R. G. et al. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73, 447-456 (1993).
89. Hintzen, R. Q., de Jong, R., Lens, S. M. & Van Uer, R. A. CD27: marker and mediator of T-cell activation? Immunol. Today 15, 307-311 (1994).
90. + lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur. J. Immunol. 22, 993-999 (1992).
91. Sallusto, F. & Lanzavecchia, A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 177, 134-140 (2000).
92. Forster, R. et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23-33 (1999).
93. + T cells specific for influenza A viruses. J. Infect. Dis. 187, 1075-1084 (2003).
94. Chen, G. et al. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 98, 156-164 (2001).
95. + subsets defined by CD57, CD27, and CD45 isoforms. Eur. J. Immunol. 29, 2908-2915 (1999).
96. + T lymphocytes. J. Immunol. 167, 181-187 (2001).
97. + T cells in healthy and immunosuppressed virus carriers. Blood 98, 754-761 (2001)
98. + T cells in peripheral blood and liver using peptide-MHC tetramers. Proc. Natl Acad. Sci. USA 96, 5692-5697 (1999).
99. Ogg, G. S. et al. Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression. J. Virol. 73, 9153-9160 (1999).
100. + T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections. Nature Med. 9, 469-476 (2003).
101. + cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. J. Infect. Dis. 183, 197-205 (2001).
102. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30, 2479-2487 (2000).
103. Croft, M. Co-stimulatory members of the TNFR family: keys to effective T cell immunity? Nature Rev. Immunol. 3, 609-620 (2003).
104. Lens, S. M. et al. Phenotype and function of human B cells expressing CD70 (CD27 ligand). Eur. J. Immunol. 26, 2964-2971 (1996).